There are currently 465 clinical trials in Kansas City, Kansas looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Kansas Medical Center, University of Kansas Cancer Center, Kansas University Medical Center and Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Post Operative Delirium Study
NCT04635774
Recruiting
Post-operative delirium happens when patients wake up from anesthesia. Patients experiencing post-operative delirium are very confused, not being able to think or function "normally". These patients are hard to take care of and they tend to have more dementia as they age compared to patients who don't experience post-operative delirium. Intranasal insulin has been shown to reverse confusion associated with Alzheimer's disease (humans) and AIDS (mice). Intranasal insulin has been safely administ... Read More
Gender:
All
Ages:
65 years and above
Trial Updated:
05/15/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Delirium
Register for Updates
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
NCT02302742
Recruiting
PROGECT is a registry for patients with Triple Negative breast cancer (TNBC) or patients who have an identified germline mutations (such as a mutation on the BRCA1 or BRCA2 genes).
Gender:
All
Ages:
All
Trial Updated:
05/08/2023
Locations: KCCC West, Kansas City, Kansas
Conditions: Breast Cancer, Hereditary Breast and Ovarian Cancer
Register for Updates
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
NCT04509050
Recruiting
This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact on children with cystic fibrosis (CF).
Gender:
All
Ages:
5 years and below
Trial Updated:
05/04/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Cystic Fibrosis
Register for Updates
A Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus
NCT05692687
Recruiting
The clinical study involves the routine treatment of skeletally mature patients who have been diagnosed with hallux rigidus (stiffness of the first metatarso-phalangeal joint in the foot due to arthritis and degeneration of cartilage). It follows standard practice surgery to treat this condition. This type of degenerative arthritis affects the joint of the big toe (hallux) which is attached to the foot. Taking part in this research will involve collecting data of the surgery to remove damaged c... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/03/2023
Locations: University of Kansas Medical Centre, Kansas City, Kansas
Conditions: Hallux Rigidus
Register for Updates
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
NCT04174157
Recruiting
Spinal muscular atrophy (SMA) is a neurogenetic disorder caused by a loss or mutation in the survival motor neuron 1 gene (SMN1) on chromosome 5q13, which leads to reduced SMN protein levels and a selective dysfunction of motor neurons. SMA is an autosomal recessive, early childhood disease with an incidence of 1:10,000 live births. SMA is the leading cause of infant mortality due to genetic diseases. Until recently, the mainstay of treatment for these patients was supportive medical care. Howe... Read More
Gender:
All
Ages:
All
Trial Updated:
04/18/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Spinal Muscular Atrophy (SMA)
Register for Updates
Phase III Trial of Sirolimus in IBM
NCT04789070
Recruiting
The hypothesis is that Sirolimus, (Rapamycin (R)) which is currently used in organ transplantation and works by blocking the activity of T effector cells but preserving T regulatory cells, as well as by inducing autophagy (protein degradation), will be effective in IBM to slow or stabilize disease progression, helping to maintain patient function and independence. This phase III trial will confirm pilot data showing statistically significant clinical outcomes.
Gender:
All
Ages:
45 years and above
Trial Updated:
04/11/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Inclusion Body Myositis
Register for Updates
Blue Light Cystoscopy With Cysview® Registry
NCT02660645
Recruiting
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/27/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Bladder Cancer
Register for Updates
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
NCT02205762
Recruiting
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).
Gender:
All
Ages:
18 years and below
Trial Updated:
03/21/2023
Locations: Children's Mercy Hospitals, Kansas City, Kansas
Conditions: Langerhans Cell Histiocytosis
Register for Updates
Changing Talk Online Training (CHATO) National Trial
NCT04610944
Recruiting
The National Plan to Address Alzheimer's disease has identified education of dementia care providers as a top priority to address the need for quality care for the population of persons with dementia that will triple in the next 30 years. This study will test new online interactive training for nursing home staff that improves staff communication and also reduces behavioral symptoms of persons with dementia that they care for. Innovative approaches to reach care providers are essential to achiev... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/14/2023
Locations: University of Kansas School of Nursing, Kansas City, Kansas
Conditions: Dementia, Alzheimer Disease, Communication
Register for Updates
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
NCT03321188
Recruiting
This study will evaluate the use of Heated Intraperitoneal Chemotherapy (HIPEC) for primary treatment of ovarian cancer at the time of surgical debulking, to assess if intravenous (IV) chemotherapy can be started within 42 days of HIPEC and cytoreduction. All patients will receive cytoreductive surgery followed by a one-time closed HIPEC with cisplatin at 41-43 degrees Celsius for 90 minutes in the operating room. This is followed by 6 cycles of intravenous carboplatin and paclitaxel on an outpa... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
02/03/2023
Locations: The University of Kansas Cancer Center, Kansas City, Kansas
Conditions: Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer
Register for Updates
Protocol for Women at Increased Risk of Developing Breast Cancer
NCT00291096
Recruiting
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
Gender:
Female
Ages:
Between 30 years and 65 years
Trial Updated:
02/02/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Breast Cancer
Register for Updates
Creatine to Augment Bioenergetics in Alzheimer's
NCT05383833
Recruiting
By doing this study, researchers hope to see if creatine monohydrate is a helpful treatment for people with Alzheimer's disease.
Gender:
All
Ages:
Between 60 years and 90 years
Trial Updated:
01/09/2023
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Alzheimer's Disease
Register for Updates